Rating
Buy
Price target
$510
Previous
$475
Implied upside
+10%

UBS analyst Timothy Arcuri raised the price target on Micron Technology (NASDAQ: MU) to $510.00 (from $475.00) while maintaining a Buy rating.

“MU reported another very strong beat and raise, but the stock faded slightly aftermarket. On one hand, we are sympathetic to the view that the beat and raise “juice” has largely played out with gross margin now guided >80%.

Feeding into this, our north star here has always been that MU peaks ~9mos ahead of peak margins and to some degree, these new strategic customer agreements will become headwinds for margins as MU trades near-term revenue for longer-term visibility.

On the other hand, the first agreement MU is signing is 5 yrs in duration – much longer than we expected – and customers would only enter into such an agreement if they saw memory as strategically critical.

Investors typically reward stocks for durability and visibility, and this is finally the evidence of the sort of lasting structural change that will drive much higher margins and ROE across the cycle.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.